The information in this section is intended for visitors outside the United States.
Gilead Recognized as Top Corporate Philanthropist in Funders Concerned About AIDS Report
Gilead HIV Medicines Now Reaching 10 Million People in Developing Countries
Statement on DISCOVER Study of F/TAF for PrEP
Gilead Supports PrEP Education to Increase HIV Prevention and Awareness
Gilead Publishes Its 2014 Corporate Contributions Report
Gilead Publishes 2015 Corporate Social Responsibility Report